Agenda
Day 1 - December 15, 2020
(all times are Eastern Standard Time)
| 10:00 am - 10:15 am |
Opening Remarks Watch video of this session |
| 10:15 am - 10:30 am |
Charge to Symposium Watch video of this session |
| 10:30 am - 11:15 am |
Keynote Watch video of this session |
|
Session One: Non-medical Cannabis Use and Cancer Epidemiology |
|
|
Co-Chairs: Gary L. Ellison, NCI, NIH and Mia Hashibe, University of Utah Watch video of this session |
|
| 11:15 am - 11:40 am | Cannabis and Cancer Risk: Current Evidence and Methodological Considerations Mia Hashibe, Huntsman Cancer Institute |
| 11:40 am - 12:05 pm | Cannabis and Tobacco Co-use: Patterns, Correlates, and Implications for Reducing Cancer Risk Amy Cohn, Stephenson Cancer Center |
| 12:05 pm - 12:30 pm | Potentially Harmful Inhalational Exposure Resulting from Smoked and Vaped Cannabis Benjamin Blount, Centers for Disease Control and Prevention |
| 12:30 pm - 1:00 pm | Panel Discussion |
| 1:00 pm - 1:15 pm | Break (15 min.) |
|
Session Two: Cannabis and the Cancer Patient |
|
|
Co-Chairs: Andrew N. Freedman, NCI, NIH and Ilana M. Braun, Dana Farber Cancer Institute Watch video of this session |
|
| 1:15 pm - 1:25 pm | A Cancer Survivor’s Experience Stacey Blansky |
| 1:25 pm - 1:50 pm | United States Legal Landscape for Medicinal Cannabis: Research & Clinical Implications Ilana Braun, Dana Farber Cancer Institute |
| 1:50 pm - 2:15 pm | Risks of Cannabis Use for the Cancer Patient Steven A. Pergam, Fred Hutchinson Cancer Research Center |
| 2:15 pm - 2:40 pm | Benefits of Cannabis Use for the Cancer Patient Donald I. Abrams, University of California San Francisco (UCSF) |
| 2:40 pm - 3:10 pm | Panel Discussion |
Day 2 - December 16, 2020
(all times are Eastern Standard Time)
| 10:00 am - 10:10 am | Introduction and Orientation to Day 2 |
|
Session Three: Cancer Symptom/Treatment Side Effect Management – Preclinical |
|
|
Co-Chairs: Yali Fu, NCI, NIH and Aron H. Lichtman, Virginia Commonwealth University (VCU) Watch video of this session |
|
| 10:10 am - 10:35 am | Targeting the Endogenous Cannabinoid System to Treat Chemotherapy-induced Peripheral Neuropathy - Leads from Preclinical Studies Aron H. Lichtman, VCU |
| 10:35 am - 11:00 am | The Endocannabinoid System and Cancer Pain Daniele Piomelli, University of California, Irvine |
| 11:00 am - 11:25 am | Cannabinoid-based Treatment Strategies for Pain Associated with Cancer Sara Jane Ward, Temple University |
| 11:25 am - 11:50 am | CBD Acid (CBDA) and CBDA Methyl Ester – Highly Effective Treatments for Nausea and Vomiting Using Preclinical Animal Models Linda Parker, University of Guelph, Canada |
| 11:50 am - 12:20 pm | Panel Discussion |
| 12:20 pm - 12:35 pm | Break (15 min.) |
|
Session Four: Cancer Symptom/Treatment Side Effect Management – Clinical |
|
|
Co-Chairs: Alexis Bakos, NCI, NIH and Mark Wallace, University of California, San Diego (UCSD) Watch video of this session |
|
| 12:35 pm - 1:00 pm | Cannabis and Pain Relief Mark Wallace, UCSD |
| 1:00 pm - 1:25 pm | Cannabinoids for Cancer-Related Nausea and Vomiting Jose M. Garcia, University of Washington |
| 1:25 pm - 1:50 pm | Cancer-Associated Anorexia and Cachexia: Defining a Palliative Role for Cannabis Aminah Jatoi, Mayo Clinic |
| 1:50 pm - 2:15 pm | Cannabis to Enhance Well-Being: A Worthwhile Goal Michelle Sexton, UCSD |
| 2:15 pm - 2:40 pm | The Clinician's Role in Medical Cannabis Care Carey S. Clark, Pacific College of Health & Science |
| 2:40 pm - 3:10 pm | Panel Discussion |
Day 3 - December 17, 2020
(all times are Eastern Standard Time)
| 10:00 am – 10:10 am | Introduction and Orientation to Day 3 |
|
Session Five: Cancer Biology and Prevention |
|
|
Co-Chairs: Sharon Ross and Ron Johnson, NCI, NIH and Sean McAllister, Sutter Health Watch video of this session |
|
| 10:10 am - 10:35 am | Cannabinoid/Cannabis Signaling and Biology Mary Abood, Temple University |
| 10:35 am - 11:00 am | Mechanism of THC Anti-tumor Activity Manuel Guzman, Complutense University of Madrid, Spain |
| 11:00 am - 11:25 am | Targeting Cancer with the Non-psychoactive Cannabinoid Cannabidiol Sean McAllister, Sutter Health |
| 11:25 am - 11:50 am | Cannabinoids and HPV-mediated OroPharynx Cancer: Genes and Weed Joseph Califano, University of California, San Diego |
| 11:50 am - 12:20 pm | Panel Discussion |
| 12:20 pm - 12:35 pm | Break (15 min.) |
|
Session Six: Cancer Treatment – Pre-Clinical & Clinical |
|
|
Co-Chairs: Jeffrey D. White, NCI, NIH and Donald I. Abrams, University of California, San Francisco (UCSF) Watch video of this session |
|
| 12:35 pm - 1:00 pm | Towards the Utilization of Cannabinoids as Anti-cancer Agents Guillermo Velasco, Complutense University of Madrid, Spain |
| 1:00 pm - 1:25 pm | Cannabinoid-mediated Novel Signaling Mechanisms in Cancer: Current Status and Future Implications Ramesh Ganju, The Ohio State University |
| 1:25 pm - 1:50 pm | A Phase 1b Randomized, Placebo-controlled Trial of Nabiximols Cannabinoid Oromucosal Spray with Temozolomide in Patients with Recurrent Glioblastoma Chris Twelves, University of Leeds, United Kingdom |
| 1:50 pm - 2:15 pm | Chronic Cannabis Use During Immunotherapy Treatment Gil Bar-Sela, Emek Medical Center, Israel |
| 2:15 pm - 2:45 pm | Panel Discussion |
Day 4 - December 18, 2020
(all times are Eastern Standard Time)
| 10:00 am - 10:10 am | Introduction and Orientation to Day 4 |
|
Session Seven: Navigating Research Challenges for Cannabis Research |
|
|
Co-Chairs: Alejandro Salicrup, NCI, NIH and Ziva D. Cooper, University of California, Los Angeles (UCLA) Watch video of this session |
|
| 10:10 am - 10:30 am | Updates on the Federal Regulatory Landscape, NIH Research Portfolio on Cannabis/Cannabinoids, and the National Institute on Drug Abuse (NIDA) Drug Supply Program Steven Gust, NIDA, NIH |
| 10:30 am - 10:50 am | Food and Drug Administration (FDA) Role in the Regulation of Cannabis Products Douglas Throckmorton, FDA |
| 10:50 am - 11:30 am | Researchers’ Point of View Regarding Challenges and Hurdles Related to Clinical Cannabis Research Ziva D. Cooper, UCLA and Donald I. Abrams, UCSF |
| 11:30 am - 12:00 pm | Panel Discussion |
| 12:00 pm - 12:10 pm | Break (10 min.) |
|
Concluding Session: What’s Next? |
|
|
Co-Chairs: Gary L. Ellison and Jeffrey D. White, NCI, NIH Watch video of this session |
|
| 12:10 pm - 1:30 pm | Panel Discussion with All External Session Co-chairs |
| 1:30 pm - 1:45 pm | Final Comments |